NCT00762281View on ClinicalTrials.gov

Safety and Effectiveness Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Hyperopia

NACompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2008

Conditions
Hyperopia
Interventions
DEVICE

MEL 80 Hyperopic LASIK Treatment

Treatment of Hyperopic corrections ≤ +6.0 D with or without Astigmatism of +0.50 to +3.50 D and MRSE ≤ +6.50 D.

Trial Locations (6)

53717

Davis Duehr Dean Eye Clinic, Madison

64055

Discover Vision Centers, Kansas City

78746

Texan Eye Care, Austin

80111

Dishler Laser Institute, Greenwood Village

92106

US Navy Refractive Surgery Center, San Diego

97401

Fine, Hoffman, and Packer, Eugene

Sponsors
All Listed Sponsors
lead

Carl Zeiss Meditec, Inc.

INDUSTRY

NCT00762281 - Safety and Effectiveness Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Hyperopia | Biotech Hunter | Biotech Hunter